Logo CICANCER

Old CIC Events

Defensa de tesis doctoral: Experimental and bioinformatic characterization of the transcriptomic profile of human Mesenchymal Stem Cells (MSCs) 01/12/2023

Defensa de tesis doctoral: Experimental and bioinformatic characterization of the transcriptomic profile of human Mesenchymal Stem Cells (MSCs)

Elena Sánchez Luis — Programa de doctorado en biociencias: Biología y clínica del cáncer y medicina traslacional

The CompleX Story of How and Why to Turn a Chromosome OFF and ON Again 30/11/2023

The CompleX Story of How and Why to Turn a Chromosome OFF and ON Again

Bernhard Payer — Centre for Genomic Regulation (CRG) Barcelona

Understanding the TGF-β signaling pathway in cholangiocarcinoma to harness its therapeutic potential 23/11/2023

Understanding the TGF-β signaling pathway in cholangiocarcinoma to harness its therapeutic potential

Javier Vaquero — Centro de Investigación del Cáncer (CSIC-Universidad de Salamanca)

Defensa de tesis doctoral: Ribosomal RNA methylation controls the cell cycle through protein synthesis 17/11/2023

Defensa de tesis doctoral: Ribosomal RNA methylation controls the cell cycle through protein synthesis

Judith López Luis — Programa de doctorado en biociencias: Biología y clínica del cáncer y medicina traslacional

Exploring immunotherapy in humanized mouse models of myeloma and lymphoma 09/11/2023

Exploring immunotherapy in humanized mouse models of myeloma and lymphoma

José Ángel Martínez Climent — Department of Hemato-Oncology. Center for Applied Medical Research (CIMA), Clinica University of Navarra Cancer Center and School of Medicine, University of Navarra

Defensa de tesis doctoral: Análisis dinámico del perfil inflamatorio einmune de pacientes con Síndrome de Respuesta Inflamatoria Sistémica (SIRS) 07/11/2023

Defensa de tesis doctoral: Análisis dinámico del perfil inflamatorio einmune de pacientes con Síndrome de Respuesta Inflamatoria Sistémica (SIRS)

Gerardo Javier Martí Chillón — Programa de doctorado en biociencias: Biología y clínica del cáncer y medicina traslacional

MAPK pathway modulation and its implications in KRAS mutant lung adenocarcinoma 02/11/2023

MAPK pathway modulation and its implications in KRAS mutant lung adenocarcinoma

Sergio de Hita Román — Centro de Investigación del Cáncer (Unviersidad de Salamanca-CSIC)

Exploring the role of senescence induced by CDK4/6 inhibitors in resistance to breast cancer treatment. 26/10/2023

Exploring the role of senescence induced by CDK4/6 inhibitors in resistance to breast cancer treatment.

David Tena Chaves — Centro de Investigación del Cáncer (CSIC-USAL), Salamanca

Signaling pathways involved in cell transformation by virally  encoded oncogenes. GPCRs, transcription factors and  strategies for sustainable research in LMI countries. 19/10/2023

Signaling pathways involved in cell transformation by virally encoded oncogenes. GPCRs, transcription factors and strategies for sustainable research in LMI countries.

Omar Coso — CONICET-Universidad de Buenos Aires, Instituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE), Buenos Aires, Argentina

Molecular basis of the response to chemotherapy and radiotherapy in head and neck cancer 05/10/2023

Molecular basis of the response to chemotherapy and radiotherapy in head and neck cancer

Mónica Álvarez Fernández — Instituto de Investigación Sanitaria del Principado de Asturias (ISPA)/ Instituto Universitario de Oncología del Principado de Asturias (IUOPA)

Altered immune response against SARS-CoV-2 infection in individuals with low-count monoclonal B-cell lymphocytosis 28/09/2023

Altered immune response against SARS-CoV-2 infection in individuals with low-count monoclonal B-cell lymphocytosis

Guillermo Oliva Ariza — Centro de Investigación del Cáncer (Universidad de Salamanca-CSIC)

PD-L2 upregulation and immune evasion in therapy-induced cellular senescence 21/09/2023

PD-L2 upregulation and immune evasion in therapy-induced cellular senescence

José Alberto López Domínguez — Cellular Plasticity and Disease laboratory, IRB Barcelona